| Neu-heart Health Care Services | |
| 7173 W Oakland Park Blvd, Fort Lauderdale, Florida 33313 | |
| (954) 724-7778 | |
| Not Available |
| Name | Neu-heart Health Care Services |
|---|---|
| Location | 7173 W Oakland Park Blvd, Fort Lauderdale, Florida |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 107647 |
| Ownership Type | Proprietary |
| Service Area Zip Codes |
| NPI Number | 1609873033 |
| Organization Name | NEU HEART HEALTHCARE SERVICES, INC. |
| Doing Business As | NEU HEART EXTENDED HOMECARE SERVICES |
| Address | 7173 West Oakland Park Boulevard, Fort Lauderdale, FL 33313 |
| Phone Number | 954-724-7778 |
News Archive
Researchers at Boston Biomedical, Inc., are working to develop a novel first-in-class cancer drug that works by targeting the stem like properties of some cancer cells, and so far, results of an ongoing Phase I clinical trial demonstrate early signs of a strong safety profile and clinical activity.
Plasmodium falciparum, the most lethal malaria parasite, is a housebreaking villain of the red blood cell world. Like a burglar searching for a way in to his targeted premises, the parasite explores a variety of potential entry points to invade the red blood cells of its human victims. When a weak point is found, the intrusion proceeds.
A new study published in the September 15, 2009, issue of PLoS ONE found that patients with cavitary pulmonary tuberculosis receiving anti-TB medications supplemented with nebulized interferon-gamma have fewer bacilli in the lungs and less inflammation, thereby reducing the transmissibility of tuberculosis in the early phase of treatment.
Despite recent advances in therapy, melanoma remains the deadliest, most aggressive form of skin cancer as incidence rates continue to climb. Now, a team of melanoma scientists from The Wistar Institute and the University of Pennsylvania received a $12.5 M, five-year program project grant (P01) from the National Institutes of Health to continue trailblazing research on targeted therapies in melanoma.
› Verified 4 days ago
| NPI Number | 1700847357 |
| Organization Name | NEU HEART EXTENDED HOMECARE SERVICES |
| Address | 7173 West Oakland Park Blvd., Fort Lauderdale, FL 33313 |
| Phone Number | 954-724-7778 |
News Archive
Researchers at Boston Biomedical, Inc., are working to develop a novel first-in-class cancer drug that works by targeting the stem like properties of some cancer cells, and so far, results of an ongoing Phase I clinical trial demonstrate early signs of a strong safety profile and clinical activity.
Plasmodium falciparum, the most lethal malaria parasite, is a housebreaking villain of the red blood cell world. Like a burglar searching for a way in to his targeted premises, the parasite explores a variety of potential entry points to invade the red blood cells of its human victims. When a weak point is found, the intrusion proceeds.
A new study published in the September 15, 2009, issue of PLoS ONE found that patients with cavitary pulmonary tuberculosis receiving anti-TB medications supplemented with nebulized interferon-gamma have fewer bacilli in the lungs and less inflammation, thereby reducing the transmissibility of tuberculosis in the early phase of treatment.
Despite recent advances in therapy, melanoma remains the deadliest, most aggressive form of skin cancer as incidence rates continue to climb. Now, a team of melanoma scientists from The Wistar Institute and the University of Pennsylvania received a $12.5 M, five-year program project grant (P01) from the National Institutes of Health to continue trailblazing research on targeted therapies in melanoma.
› Verified 4 days ago
| Quality Rating: | Not Available* |
| * This measure currently does not have data or provider has been certified/recertified for less than 6 months. | |
News Archive
Researchers at Boston Biomedical, Inc., are working to develop a novel first-in-class cancer drug that works by targeting the stem like properties of some cancer cells, and so far, results of an ongoing Phase I clinical trial demonstrate early signs of a strong safety profile and clinical activity.
Plasmodium falciparum, the most lethal malaria parasite, is a housebreaking villain of the red blood cell world. Like a burglar searching for a way in to his targeted premises, the parasite explores a variety of potential entry points to invade the red blood cells of its human victims. When a weak point is found, the intrusion proceeds.
A new study published in the September 15, 2009, issue of PLoS ONE found that patients with cavitary pulmonary tuberculosis receiving anti-TB medications supplemented with nebulized interferon-gamma have fewer bacilli in the lungs and less inflammation, thereby reducing the transmissibility of tuberculosis in the early phase of treatment.
Despite recent advances in therapy, melanoma remains the deadliest, most aggressive form of skin cancer as incidence rates continue to climb. Now, a team of melanoma scientists from The Wistar Institute and the University of Pennsylvania received a $12.5 M, five-year program project grant (P01) from the National Institutes of Health to continue trailblazing research on targeted therapies in melanoma.
› Verified 4 days ago
News Archive
Researchers at Boston Biomedical, Inc., are working to develop a novel first-in-class cancer drug that works by targeting the stem like properties of some cancer cells, and so far, results of an ongoing Phase I clinical trial demonstrate early signs of a strong safety profile and clinical activity.
Plasmodium falciparum, the most lethal malaria parasite, is a housebreaking villain of the red blood cell world. Like a burglar searching for a way in to his targeted premises, the parasite explores a variety of potential entry points to invade the red blood cells of its human victims. When a weak point is found, the intrusion proceeds.
A new study published in the September 15, 2009, issue of PLoS ONE found that patients with cavitary pulmonary tuberculosis receiving anti-TB medications supplemented with nebulized interferon-gamma have fewer bacilli in the lungs and less inflammation, thereby reducing the transmissibility of tuberculosis in the early phase of treatment.
Despite recent advances in therapy, melanoma remains the deadliest, most aggressive form of skin cancer as incidence rates continue to climb. Now, a team of melanoma scientists from The Wistar Institute and the University of Pennsylvania received a $12.5 M, five-year program project grant (P01) from the National Institutes of Health to continue trailblazing research on targeted therapies in melanoma.
› Verified 4 days ago
Integrity Health Services Location: 7771 W Oakland Park Blvd, Ste 218, Fort Lauderdale, Florida 33351 Ratings: NA Phone: (954) 485-4804 | |
Elite Home Health Services Llc Location: 2691 E Oakland Park Blvd Ste 403-a, Fort Lauderdale, Florida 33306 Ratings: Phone: (954) 267-9029 | |
Gold Coast Home Health Services Location: 309 Se 18th St, Fort Lauderdale, Florida 33316 Ratings: Phone: (954) 785-2990 | |
Carter Healthcare Location: 2745 W Cypress Creek Rd Ste A, Fort Lauderdale, Florida 33309 Ratings: Phone: (954) 971-0500 | |
Community Home Health Services Location: 6555 Nw 9th Ave Ste 103, Fort Lauderdale, Florida 33309 Ratings: Phone: (954) 973-9400 | |
Mederi Caretenders Location: 4901 Nw 17th Way Ste 302a, Fort Lauderdale, Florida 33309 Ratings: Phone: (954) 484-4837 |